Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024. 

"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."

Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month. 

The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses. 

Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent. 

Share:
More In Business
Be Well: Tips to Track Your Personal Spending
Staying on top of your personal spending shouldn't be as complicated as you think. Lazetta Braxton, a certified financial planner, joined Cheddar News to provide tips on how to track that spending, such as grouping expenses into different categories.
Ready4Work Tips for Those That Have Been Laid Off
Studies show about half of Americans will experience a layoff in their lifetime. Cheddar News' Ready4Work docuseries on Thursdays at 8:30pm provides tips in its latest episode on what to do if you get that pink slip.
Load More